47 related articles for article (PubMed ID: 1742733)
1. Factors influencing mutation at the hprt locus in T-lymphocytes: women treated for breast cancer.
Branda RF; O'Neill JP; Sullivan LM; Albertini RJ
Cancer Res; 1991 Dec; 51(24):6603-7. PubMed ID: 1742733
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing mutation at the hprt locus in T-lymphocytes: studies in normal women and women with benign and malignant breast masses.
Branda RF; O'Neill JP; Jacobson-Kram D; Albertini RJ
Environ Mol Mutagen; 1992; 19(4):274-81. PubMed ID: 1600953
[TBL] [Abstract][Full Text] [Related]
3. Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy.
Karnaoukhova L; Moffat J; Martins H; Glickman B
Cancer Res; 1997 Oct; 57(19):4393-407. PubMed ID: 9331103
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of hprt mutant and mutation frequencies in treated cancer patients.
Caggana M; Liber HL; Coleman CN; Mauch P; Clark JR; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1992; 1(7):573-80. PubMed ID: 1302570
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy--induced mucositis and neutropenia.
Branda RF; Naud SJ; Brooks EM; Chen Z; Muss H
Cancer; 2004 Sep; 101(5):1058-64. PubMed ID: 15329916
[TBL] [Abstract][Full Text] [Related]
6. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
Beland FA
Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of mutant frequencies at the hprt and T-cell receptor gene loci in pediatric cancer patients during chemotherapy.
Sawada M; Kubota M; Lin YW; Watanabe K; Koishi S; Usami I; Akiyama Y; Matsumura T; Furusho K
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):711-7. PubMed ID: 9718224
[TBL] [Abstract][Full Text] [Related]
8. The influence of breast cancer treatment on the occurrence of hot flashes.
Savard MH; Savard J; Quesnel C; Ivers H
J Pain Symptom Manage; 2009 Apr; 37(4):687-97. PubMed ID: 18973980
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers.
Jones IM; Moore DH; Thomas CB; Thompson CL; Strout CL; Burkhart-Schultz K
Cancer Epidemiol Biomarkers Prev; 1993; 2(3):249-60. PubMed ID: 8318878
[TBL] [Abstract][Full Text] [Related]
11. Differences in fatigue by treatment methods in women with breast cancer.
Woo B; Dibble SL; Piper BF; Keating SB; Weiss MC
Oncol Nurs Forum; 1998 Jun; 25(5):915-20. PubMed ID: 9644708
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
15. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
[TBL] [Abstract][Full Text] [Related]
16. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
[TBL] [Abstract][Full Text] [Related]
17. Monitoring hprt mutant frequency over time in T-lymphocytes of people accidentally exposed to high doses of ionizing radiation.
da Cruz AD; Curry J; Curado MP; Glickman BW
Environ Mol Mutagen; 1996; 27(3):165-75. PubMed ID: 8625952
[TBL] [Abstract][Full Text] [Related]
18. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
20. Frequency of sister chromatid exchanges and micronuclei monitored over time in patients with early-stage breast cancer: results of an observational study.
Aristei C; Stracci F; Guerrieri P; Anselmo P; Armellini R; Rulli A; Barberini F; Latini P; Menghini AR
Cancer Genet Cytogenet; 2009 Jul; 192(1):24-9. PubMed ID: 19480933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
